← Back to NAMS

NewAmsterdam Pharma Company N.V. - Ordinary Shares financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 05/08/2026Mar 2026Filed 07/05/2026Sep 2025Filed 05/11/2025Jun 2025Filed 05/08/2026Mar 2025Filed 07/05/2026Sep 2024Filed 05/11/2025Jun 2024Filed 06/08/2025Mar 2024Filed 08/05/2025
$3.7$3$0.3$19$3$29$2.3$1.4
−$64−$48−$72−$17−$40−$17−$39−$94
−$0.52−$0.40−$0.61−$0.15−$0.34−$0.18−$0.41−$1.06
123122119119116959588

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.